Low-density lipoprotein lowering and atherosclerosis progression: does more mean less?
Shah
Prediman K
PK
D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D000069059:Atorvastatin; D002339:Carotid Arteries / Q000000981:diagnostic imaging / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood*; D018450:Disease Progression; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy; D008055:Lipids / Q000097:blood; D017035:Pravastatin / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*; D014463:Ultrasonography
D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D011758:Pyrroles; D002784:Cholesterol; D000069059:Atorvastatin; D017035:Pravastatin